Future studies using proteomic approaches would be useful to understand if the AR-BiP protein complex that occurs after α-mangostin treatment in PCa cells contains α-mangostin, which would give rise to the thought that α-mangostin itself may be binding to BiP and activating BiP to promote AR degradation. The gene discussed is HSPA5; the disease is posterior cortical atrophy.